4
Changes in Ownership
Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-012797
Director acquired 8,424 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Velleca Mark A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-16 | Grant or award : show line 1 in the form | +8,424 | $1.50 | $12,636 | 21,157 | D |
Loading xslF345X03/form4-12202022_021242.xml…